• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Recurrent and Treatment-Unresponsive Spontaneous Bacterial Peritonitis Worsens survival in Decompensated Liver Cirrhosis.复发性及治疗无反应性自发性细菌性腹膜炎会恶化失代偿期肝硬化患者的生存状况。
J Clin Exp Hepatol. 2021 May-Jun;11(3):334-342. doi: 10.1016/j.jceh.2020.08.010. Epub 2020 Sep 6.
2
Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites.肝硬化腹水患者自发性细菌性腹膜炎发生及后续死亡的危险因素。
Liver Int. 2015 Sep;35(9):2121-8. doi: 10.1111/liv.12795. Epub 2015 Feb 18.
3
Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis.腹水样本中MFAP4的水平可独立预测肝硬化患者1年无移植生存率。
JHEP Rep. 2021 Mar 29;3(3):100287. doi: 10.1016/j.jhepr.2021.100287. eCollection 2021 Jun.
4
Determinants of Outcomes in Autoimmune Hepatitis Presenting as Acute on Chronic Liver Failure Without Extrahepatic Organ Dysfunction upon Treatment With Steroids.自身免疫性肝炎表现为慢性肝衰竭急性发作且在使用类固醇治疗时无肝外器官功能障碍的预后决定因素
J Clin Exp Hepatol. 2021 Mar-Apr;11(2):171-180. doi: 10.1016/j.jceh.2020.08.007. Epub 2020 Aug 22.
5
Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.预测广泛肝病患者的死亡率——对终末期肝病模型(MELD)、Child-Turcotte-Pugh(CTP)评分以及肌酐修正CTP评分的评估
J Clin Exp Hepatol. 2011 Dec;1(3):161-8. doi: 10.1016/S0973-6883(11)60233-8. Epub 2012 Jan 2.
6
EVALUATION OF PROGNOSTIC FACTORS IN DECOMPENSATED LIVER CIRRHOSIS WITH ASCITES AND SPONTANEOUS BACTERIAL PERITONITIS.伴有腹水和自发性细菌性腹膜炎的失代偿期肝硬化预后因素评估
Rev Med Chir Soc Med Nat Iasi. 2015 Oct-Dec;119(4):1018-24.
7
Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.评估肝硬化患者腹水及自发性细菌性腹膜炎导致失代偿的风险。
Rev Med Chir Soc Med Nat Iasi. 2014 Apr-Jun;118(2):320-6.
8
Lymphocyte-To-Monocyte Ratio as the Best Simple Predictor of Bacterial Infection in Patients with Liver Cirrhosis.淋巴细胞单核细胞比值是预测肝硬化患者细菌感染的最佳简单指标。
Int J Environ Res Public Health. 2020 Mar 6;17(5):1727. doi: 10.3390/ijerph17051727.
9
[The predictive value of end-stage liver disease model for spontaneous bacterial peritonitis in cirrhotic patients with ascites].[终末期肝病模型对肝硬化腹水患者自发性细菌性腹膜炎的预测价值]
Zhonghua Nei Ke Za Zhi. 2009 Aug;48(8):629-32.
10
Ascitic fluid infection in patients with hepatitis B virus-related liver cirrhosis: culture-negative neutrocytic ascites versus spontaneous bacterial peritonitis.乙型肝炎病毒相关肝硬化患者腹水感染:培养阴性中性粒细胞性腹水与自发性细菌性腹膜炎。
J Gastroenterol Hepatol. 2010 Jan;25(1):122-8. doi: 10.1111/j.1440-1746.2009.05970.x. Epub 2009 Oct 19.

引用本文的文献

1
Variables associated with antibiotic administration for performing paracentesis among patients with ascites in a community hospital.社区医院腹水患者进行腹腔穿刺术时与抗生素使用相关的变量。
Clin Exp Hepatol. 2024 Mar;10(1):47-52. doi: 10.5114/ceh.2024.136215. Epub 2024 Mar 28.
2
Human Amniotic MSC Response in LPS-Stimulated Ascites from Patients with Cirrhosis: FOXO1 Gene and Th17 Activation in Enhanced Antibacterial Activation.人羊膜间充质干细胞对肝硬化腹水 LPS 刺激的反应:FOXO1 基因和 Th17 激活增强抗菌激活。
Int J Mol Sci. 2024 Feb 28;25(5):2801. doi: 10.3390/ijms25052801.
3
Serum copeptin is associated with major complications of liver cirrhosis and spontaneous bacterial peritonitis.血清 copeptin 与肝硬化和自发性细菌性腹膜炎的主要并发症相关。
Clin Exp Hepatol. 2023 Mar;9(1):71-78. doi: 10.5114/ceh.2023.125970. Epub 2023 Mar 21.
4
Therapeutic effect of autologous bone marrow cells injected into the liver under the guidance of B‑ultrasound in the treatment of HBV‑related decompensated liver cirrhosis.B超引导下自体骨髓细胞注入肝脏治疗HBV相关失代偿期肝硬化的疗效
Exp Ther Med. 2022 Aug 22;24(4):633. doi: 10.3892/etm.2022.11570. eCollection 2022 Oct.
5
Overview of Complications in Cirrhosis.肝硬化并发症概述
J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1150-1174. doi: 10.1016/j.jceh.2022.04.021. Epub 2022 May 14.
6
Establishment and Validation of a Non-Invasive Diagnostic Nomogram to Identify Spontaneous Bacterial Peritonitis in Patients With Decompensated Cirrhosis.用于识别失代偿期肝硬化患者自发性细菌性腹膜炎的无创诊断列线图的建立与验证
Front Med (Lausanne). 2022 Jan 31;8:797363. doi: 10.3389/fmed.2021.797363. eCollection 2021.
7
Application of mNGS in the Etiological Diagnosis of Thoracic and Abdominal Infection in Patients With End-Stage Liver Disease.mNGS 在终末期肝病患者胸腹部感染病因诊断中的应用。
Front Cell Infect Microbiol. 2022 Jan 5;11:741220. doi: 10.3389/fcimb.2021.741220. eCollection 2021.

本文引用的文献

1
Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals.肝硬化住院结局的早期预测指标及评价保障性医院中种族和民族的影响。
PLoS One. 2019 Mar 6;14(3):e0211811. doi: 10.1371/journal.pone.0211811. eCollection 2019.
2
Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies.肝硬化患者的自发性细菌性腹膜炎:发病率、转归及治疗策略。
Hepat Med. 2019 Jan 14;11:13-22. doi: 10.2147/HMER.S164250. eCollection 2019.
3
Predictors of Spontaneous Bacterial Peritonitis in Patients with Cirrhotic Ascites.肝硬化腹水患者自发性细菌性腹膜炎的预测因素
J Clin Transl Hepatol. 2018 Dec 28;6(4):372-376. doi: 10.14218/JCTH.2018.00001. Epub 2018 Jul 18.
4
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.全球肝硬化患者细菌感染的流行病学和影响。
Gastroenterology. 2019 Apr;156(5):1368-1380.e10. doi: 10.1053/j.gastro.2018.12.005. Epub 2018 Dec 13.
5
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.欧洲肝脏研究学会失代偿期肝硬化患者管理临床实践指南
J Hepatol. 2018 Aug;69(2):406-460. doi: 10.1016/j.jhep.2018.03.024. Epub 2018 Apr 10.
6
Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review.肝硬化患者的自发性细菌性和真菌性腹膜炎:文献综述
World J Hepatol. 2018 Feb 27;10(2):254-266. doi: 10.4254/wjh.v10.i2.254.
7
Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis: a multicenter cohort study.自发性细菌性腹膜炎患者死亡相关的临床和微生物学特征:一项多中心队列研究
Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1216-22. doi: 10.1097/MEG.0000000000000700.
8
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial.医院获得性自发性细菌性腹膜炎的经验性抗生素治疗:一项随机对照临床试验的结果。
Hepatology. 2016 Apr;63(4):1299-309. doi: 10.1002/hep.27941. Epub 2015 Aug 4.
9
Review article: spontaneous bacterial peritonitis--bacteriology, diagnosis, treatment, risk factors and prevention.综述文章:自发性细菌性腹膜炎——细菌学、诊断、治疗、危险因素和预防。
Aliment Pharmacol Ther. 2015 Jun;41(11):1116-31. doi: 10.1111/apt.13172. Epub 2015 Mar 26.
10
Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites.肝硬化腹水患者自发性细菌性腹膜炎发生及后续死亡的危险因素。
Liver Int. 2015 Sep;35(9):2121-8. doi: 10.1111/liv.12795. Epub 2015 Feb 18.

复发性及治疗无反应性自发性细菌性腹膜炎会恶化失代偿期肝硬化患者的生存状况。

Recurrent and Treatment-Unresponsive Spontaneous Bacterial Peritonitis Worsens survival in Decompensated Liver Cirrhosis.

作者信息

Falleti Edmondo, Cmet Sara, Cussigh Anna R, Salvador Elena, Bitetto Davide, Fornasiere Ezio, Fumolo Elisa, Fabris Carlo, Toniutto Pierluigi

机构信息

Clinical Pathology, Laboratory Medicine, Azienda Sanitaria Universitaria Integrata, Udine, Italy.

Hepatology and Liver Transplantation Unit, Azienda Sanitaria Universitaria Integrata, Udine, Italy.

出版信息

J Clin Exp Hepatol. 2021 May-Jun;11(3):334-342. doi: 10.1016/j.jceh.2020.08.010. Epub 2020 Sep 6.

DOI:10.1016/j.jceh.2020.08.010
PMID:33994716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8103328/
Abstract

BACKGROUND

Spontaneous bacterial peritonitis (SBP) remains a major complication of cirrhosis. However, the incidence and the real impact of SBP in determining patient survival rates remain unclear. This study aims to evaluate the incidence and risk factors for SBP development and the role of SBP in predicting transplant-free survival.

METHODS

Two hundred two consecutive patients underwent 492 paracenteses with biochemical and microbiological analysis of the ascitic fluid. When multiple paracenteses had been performed on a given patient, the first SBP-positive paracentesis or the first paracentesis conducted when none was diagnostic for SBP was included in the study.

RESULTS

SBP was detected in 28 of 202 (13.9%) patients; in 26 of 28 patients, the neutrophil count in the ascitic fluid was ≥250 cells/μl, and in 15 of 28 patients, the cultures were positive. Variables independently associated with SBP were as follows: a higher model of end-stage liver disease (MELD) score, the serum glucose value, elevated CRP serum levels, and higher potassium serum levels. Overall, the median (range) transplant-free survival was 289 (54-1253) days. One hundred (49.5%) patients died, whereas 35 patients (17.3%) underwent liver transplantation. Independent predictors of death or liver transplantation were a higher MELD score and the development of SBP, especially if it was antibiotic-resistant or recurrent SBP.

CONCLUSION

The occurrence of SBP is associated with more severe liver dysfunction in conjunction with the presence of inflammation. Unlike the occurrence of SBP , failure of first-line antibiotic treatment and SBP recurrence appear to strongly influence the mortality rate.

摘要

背景

自发性细菌性腹膜炎(SBP)仍是肝硬化的主要并发症。然而,SBP的发病率及其在确定患者生存率方面的实际影响仍不明确。本研究旨在评估SBP发生的发病率、危险因素以及SBP在预测无移植生存率方面的作用。

方法

202例连续患者接受了492次腹腔穿刺,并对腹水进行了生化和微生物学分析。当对某一患者进行了多次腹腔穿刺时,纳入研究的是首次SBP阳性的腹腔穿刺或首次未诊断出SBP时进行的腹腔穿刺。

结果

202例患者中有28例(13.9%)检测到SBP;28例患者中有26例腹水中性粒细胞计数≥250个/μl,28例患者中有15例培养结果为阳性。与SBP独立相关的变量如下:终末期肝病(MELD)评分较高、血清葡萄糖值、血清CRP水平升高以及血清钾水平较高。总体而言,无移植生存的中位(范围)时间为289(54 - 1253)天。100例(49.5%)患者死亡,而35例患者(17.3%)接受了肝移植。死亡或肝移植的独立预测因素是较高的MELD评分和SBP的发生,尤其是耐药性SBP或复发性SBP。

结论

SBP的发生与更严重的肝功能不全以及炎症的存在相关。与SBP的发生不同,一线抗生素治疗失败和SBP复发似乎对死亡率有强烈影响。